Home › NCT04904757
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
RecruitingHealthy volunteers welcome
Willingness of Women to Undergo a Contrast-enhanced Spectral Mammography (CESM) for Breast Cancer Screening and Their Experience Before and After CESM
Who can join
Ages 40 to 69 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * • Female * 40 to 69 years * Previous normal mammogram (BI-RADS 1 or 2) showing heterogeneous or extremely dense breast tissue within last 24 months * Scheduled for screening mammogram as part of the patient's clinical care Exclusion Criteria: * • No mammogram within last 24 months * Fatty or scattered fibroglandular tissue on last mammogram * History of allergy to iodinated contrast * History of renal disease or renal function abnormalities * Pregnant women * History of diabetes * History of paraproteinemia syndromes such as multiple myeloma * History of collagen vascular disease * History of vascular disease (coronary artery disease, myocardial infarction, carotid disease, peripheral vascular disease, or known visceral artery disease) * Previously identified as high risk for breast cancer (\>20% lifetime risk) * Asthma * Sickle Cell Anemia * Currently on Dialysis
About the study
The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.
What is being tested
- Contrast-enhanced spectral mammography (CESM) (device)
Sponsor: University of Virginia · Participants: 210 · Started: Sep 19, 2019
Contact the study team
- Kathy L Repich, RN · Phone: 4342434540
Official record on ClinicalTrials.gov — NCT04904757
Locations in the U.S.
| Virginia | UVA Breast Care Center, Charlottesville |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.